Pixium Vision
Develops bionic retinal implants to restore partial sight for macular degeneration patients.
ALPIX | PA
Overview
Corporate Details
- ISIN(s):
- FR0011950641 (+1 more)
- LEI:
- 96950046OPLRLKKEOO08
- Country:
- France
- Address:
- 74 RUE DU FBG ST ANTOINE, 75012 PARIS 12
- Website:
- https://www.pixium-vision.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of irradiation, electromedical and electrotherapeutic equipment
Description
Pixium Vision was a medical technology company that developed bionic vision systems to restore partial sight in patients with severe vision loss. Its flagship product is the PRIMA System, an innovative, wireless, photovoltaic sub-retinal implant. The system is designed for patients suffering from atrophic dry age-related macular degeneration (Dry-ARMD). It functions by converting light into electrical signals to stimulate retinal neurons, creating a form of artificial vision. The assets of Pixium Vision SA, including the PRIMA technology and its ongoing clinical trials, have been acquired by Science Corporation. La Science SAS is the current legal manufacturer and sponsor of the European clinical trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-02-02 14:00 |
Legal Proceedings Report
Pixium Vision announces the rejection of the sale plan (plan de cession) by the…
|
English | 156.7 KB | ||
| 2024-02-02 14:00 |
Legal Proceedings Report
Pixium Vision annonce le rejet du plan de cession par le Tribunal et la convers…
|
French | 165.4 KB | ||
| 2024-01-17 17:00 |
Legal Proceedings Report
Postponement of the decision on the adoption of a sale plan (plan de cession) a…
|
English | 157.2 KB | ||
| 2024-01-17 17:00 |
Legal Proceedings Report
Report de la décision concernant l’arrêté d’un plan de cession et l’ouverture d…
|
French | 165.3 KB | ||
| 2024-01-17 07:00 |
Legal Proceedings Report
Report de la décision concernant l’arrêté d’un plan de cession et l’ouverture d…
|
French | 164.0 KB | ||
| 2024-01-17 07:00 |
Legal Proceedings Report
Postponement of the decision on the adoption of a sale plan (plan de cession) a…
|
English | 156.4 KB | ||
| 2023-12-18 19:00 |
Legal Proceedings Report
Decision concerning the adoption of a sale plan (plan de cession) and the openi…
|
English | 157.8 KB | ||
| 2023-12-18 19:00 |
Legal Proceedings Report
Décision concernant l’arrêté d’un plan de cession et l’ouverture d’une procédur…
|
French | 166.4 KB | ||
| 2023-12-04 07:00 |
Legal Proceedings Report
Audience d’examen de l’offre de reprise par le Tribunal de commerce prévue le 1…
|
French | 167.1 KB | ||
| 2023-12-04 07:00 |
Legal Proceedings Report
Commercial Court hearing to examine the takeover offer scheduled for December 1…
|
English | 156.6 KB | ||
| 2023-11-20 17:45 |
Legal Proceedings Report
Point sur la procédure de redressement judiciaire : dépôt d’une offre de repris…
|
French | 165.4 KB | ||
| 2023-11-20 17:45 |
Legal Proceedings Report
Update on the receivership proceedings: submission of a takeover offer to the c…
|
English | 180.7 KB | ||
| 2023-11-14 07:00 |
Legal Proceedings Report
Pixium Vision annonce les résultats de l'essai à 48 mois sur la DMLA atrophique…
|
French | 284.3 KB | ||
| 2023-11-14 07:00 |
Legal Proceedings Report
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD
|
English | 263.7 KB | ||
| 2023-11-13 20:00 |
Legal Proceedings Report
Pixium Vision annonce la conversion de sa procédure de sauvegarde en redresseme…
|
French | 167.8 KB |
Automate Your Workflow. Get a real-time feed of all Pixium Vision filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Pixium Vision via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-10 | N/A | Other | Sell | 42,681 | 16,517.55 EUR |
| 2024-01-09 | N/A | Other | Sell | 80,325 | 45,608.54 EUR |
| 2024-01-08 | N/A | Other | Sell | 110,740 | 69,732.98 EUR |
| 2023-12-04 | N/A | Other | Sell | 665 | 60.98 EUR |
